diabetes mellitus, type 2

Showing NaN - NaN of 73

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Type 2, Peripheral Arterial Disease Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Recruiting
  • Diabetes Mellitus, Type 2
  • Peripheral Arterial Disease
  • Birmingham, Alabama
  • +179 more
Jan 23, 2023

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, sitagliptin, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +241 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Little Rock, Arkansas
  • +228 more
Jul 11, 2022

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Montgomery, Alabama
  • +444 more
Mar 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin degludec)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Faster-acting insulin aspart
  • +3 more
  • Concord, California
  • +166 more
Jan 6, 2022

Ischemic Heart Disease Chronic, Diabetes, Type 2 Trial in Germany (lifestyle intervention, usual care)

Completed
  • Ischemic Heart Disease Chronic
  • Diabetes Mellitus, Type 2
  • lifestyle intervention
  • usual care
  • Aachen, Germany
  • +9 more
Nov 4, 2021

Diabetes, Type 2, Coronary Artery Disease Trial in Worldwide (Apabetalone, Placebo, Atorvastatin)

Completed
  • Diabetes Mellitus, Type 2
  • Coronary Artery Disease
  • Bahía Blanca, Argentina
  • +213 more
Jul 23, 2021

Looking at How Semaglutide Works in People With Type 2 Diabetes

Completed
  • Diabetes Mellitus, Type 2
  • Amberg, Germany
  • +94 more
Jul 23, 2021

Hyperlipidemia, Diabetes, Type 2, Non-Insulin Dependent Diabetes Trial in Germany (Atorvastatin, Placebo)

Terminated
  • Hyperlipidemia
  • +2 more
  • BAD Muenster AM Stein, Germany
  • +13 more
Feb 17, 2021

Diabetes, Type 2 Trial in Worldwide (Albiglutide, Insulin Glargine and Insulin Lispro)

Completed
  • Diabetes Mellitus, Type 2
  • Searcy, Arkansas
  • +157 more
Nov 13, 2020

Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )

Completed
  • Diabetes Mellitus, Type 2
  • Ticagrelor 60 mg
  • Ticagrelor placebo
  • Alexander City, Alabama
  • +1241 more
Mar 4, 2020

Insulin Therapy in Type 2 Diabetes

Completed
  • Diabetes Mellitus, Type 2
    • Little Rock, Arkansas
    • +152 more
    Feb 25, 2020

    Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )

    Completed
    • Diabetes Mellitus, Type 2
    • Athens, Alabama
    • +612 more
    Dec 19, 2019

    Diabetes, Type 2, Diabetic Nephropathy Trial in Worldwide (Canagliflozin, Placebo)

    Completed
    • Diabetes Mellitus, Type 2
    • Diabetic Nephropathy
    • Birmingham, Alabama
    • +592 more
    Dec 4, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, Dulaglutide)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Tuscumbia, Alabama
    • +208 more
    Oct 2, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Liraglutide)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Burgas, Bulgaria
    • +91 more
    Oct 2, 2019

    Cardiovascular Disease, Diabetes, Type 2 Trial in Worldwide (Dulaglutide, Placebo)

    Completed
    • Cardiovascular Disease
    • Diabetes Mellitus, Type 2
    • Mobile, Alabama
    • +300 more
    Sep 18, 2019

    Diabetes, Type 2 Trial in Worldwide (Human Insulin Inhalation Powder, Insulin Glargine)

    Completed
    • Diabetes Mellitus, Type 2
    • Human Insulin Inhalation Powder
    • Insulin Glargine
    • Fresno, California
    • +68 more
    Sep 6, 2019

    Diabetes, Type 2 Trial in Worldwide (Human Insulin Inhalation Powder, Injectable insulin)

    Completed
    • Diabetes Mellitus, Type 2
    • Human Insulin Inhalation Powder
    • Injectable insulin
    • Sacramento, California
    • +42 more
    Sep 6, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Alabaster, Alabama
    • +427 more
    Jul 3, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, exenatide)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Anniston, Alabama
    • +145 more
    May 28, 2019

    Diabetes, Type 2 Trial in Worldwide (Placebo, Linagliptin)

    Completed
    • Diabetes Mellitus, Type 2
    • Huntsville, Alabama
    • +648 more
    Mar 21, 2019

    Diabetes, Type 2, Albuminuria Trial in Worldwide (Placebo, Canagliflozin, 100 mg, Canagliflozin, 300 mg)

    Completed
    • Diabetes Mellitus, Type 2
    • Albuminuria
    • Placebo
    • +2 more
    • Little Rock, Arkansas
    • +353 more
    Nov 19, 2018

    Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

    Completed
    • Diabetes Mellitus, Type 2
    • +2 more
    • Placebo
    • +2 more
    • Birmingham, Alabama
    • +312 more
    Nov 5, 2018

    Diabetes, Type 2 Trial in Worldwide (LY2409021, Placebo)

    Completed
    • Diabetes Mellitus, Type 2
    • Burbank, California
    • +39 more
    Mar 24, 2018